Intézmény

Dokuz Eylül University

Izmir, TörökországHonlap

Más néven: Dokuz Eylül Üniversitesi · DEÜ

25futó vizsgálat
15lezárt vizsgálat
1kutató
40 985publikáció (OpenAlex)

Kutatók

Kübra Canaslan

Futó vizsgálatok

Még nem toboroz
QIPB vs SI-FICB for Postoperative Analgesia After Total Hip Arthroplasty
NCT07683663· Dokuz Eylul University· Forrás
Toboroz
Extracorporeal Shock Wave Therapy in the Treatment of Periarticular Bone Marrow Edema in Patients With Knee Osteoarthritis
NCT07887893· Dokuz Eylul University· Forrás
Toboroz
Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease
NCT07497360· Izmir Democracy University· Forrás
Toboroz
Speech-based Assessment of Relapse Risk in People With Psychosis
NCT07397975· Philipp Homan· Forrás
Fut, nem toboroz
The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors
NCT07205965· Dokuz Eylul University· Forrás
Még nem toboroz
Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer
NCT06823297· Turkish Society of Colon and Rectal Surgery· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Még nem toboroz
Endoscopic Submucosal Dissection vs. Transanal Endoscopic Surgery for Rectal Neoplasia
NCT06902701· Turkish Society of Colon and Rectal Surgery· Forrás
Toboroz
Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue
NCT07040657· Dokuz Eylul University· Forrás
Toboroz
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
NCT06846671· 3. fázis· BeOne Medicines· Forrás
Toboroz
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990· 2/3. fázis· Bicara Therapeutics· Forrás
Fut, nem toboroz
Online Diabetic Foot Support Program- Care Kit
NCT06760416· Merve GÃnbaAY· Forrás
Fut, nem toboroz
Hypoglycemia Prevention and Awareness Program
NCT06775288· Merve DerviAYoAYlu· Forrás
Toboroz
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
NCT06463587· 3. fázis· Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany· Forrás
Meghívásos bevonás
Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery
NCT06774170· Dokuz Eylul University· Forrás
Toboroz
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
NCT06149286· 3. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
NCT06091865· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
NCT05152147· 3. fázis· Jazz Pharmaceuticals· Forrás
Toboroz
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716· 1/2. fázis· BeOne Medicines· Forrás
Fut, nem toboroz
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT04666038· 3. fázis· Loxo Oncology, Inc.· Forrás
Fut, nem toboroz
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
NCT04232553· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
NCT04166565· 2. fázis· Stichting European Myeloma Network· Forrás
Fut, nem toboroz
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
NCT03711032· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Fut, nem toboroz
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
NCT03229200· 4. fázis· Pharmacyclics Switzerland GmbH· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
Follikuláris limfóma2 toboroz
Krónikus limfoid leukémia (CLL)2 toboroz
Osteoarthritis2 toboroz
Vastagbélrák2 toboroz
2-es típusú cukorbetegség1 toboroz
Fej-nyaki daganatok1 toboroz
Gyermekkori daganatok1 toboroz
Hasnyálmirigyrák1 toboroz
Köpenysejtes limfóma1 toboroz
Magas vérnyomás1 toboroz
Méhtestrák1 toboroz
Myasthenia gravis1 toboroz
Peripheral artery disease1 toboroz
Skizofrénia1 toboroz

Lezárt vizsgálatok

Lezárult
The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses
NCT06653673· Dokuz Eylul University· Forrás
Lezárult
Reliability of BASDAI and BASFI Applied by Tele-Assessment Method in Axial SpA Spondyloarthritis
NCT06230952· Siirt University· Forrás
Lezárult
Online Diabetes Clinic Support Program
NCT06767865· Dilek Büyükkaya Besen· Forrás
Lezárult
Acute Responses of Active Video Games and Traditional Exercise Program in in Patients With Pulmonary Hypertension
NCT05901168· Dokuz Eylul University· Forrás
Lezárult
Early-phase Exercise-based Cardiac Rehabilitation After MI
NCT06924034· Dokuz Eylul University· Forrás
Lezárult
Validity and Reliability of 30SFPW Test Patients With TKA
NCT06202170· Dokuz Eylul University· Forrás
Lezárult
Lifestyle Change in Women With Polycystic Ovary Syndrome
NCT05377021· Dokuz Eylul University· Forrás
Lezárult
The Effects of Exercise on Gait Characteristics, Balance, and Performance in Patients With Normal Pressure Hydrocephalus
NCT05679934· Dokuz Eylul University· Forrás
Lezárult
Investigation of the Effects of Family-Focused Therapy in the Early Period of Bipolar Disorder and Psychotic Disorder
NCT05809193· Dokuz Eylul University· Forrás
Lezárult
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
NCT05008224· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
Yoga and Aerobic Exercise in Epilepsy
NCT05066880· Dokuz Eylul University· Forrás
Leállították
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
NCT04551066· 3. fázis· Incyte Corporation· Forrás
Lezárult
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
NCT04732221· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
NCT03867084· 3. fázis· Merck Sharp & Dohme LLC· Forrás

Regiszterbeli névváltozatok (12)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

Dokuz Eylul University
Izmir, Balcova Inciralti 35340
23 vizsgálat
Dokuz Eylül Üniversitesi
Balçova, İzmir 35340
3 vizsgálat
Dokuz Eylul University
Balçova, 35330
3 vizsgálat
Dokuz Eylul University Faculty of Medicine
Izmir, 35330
3 vizsgálat
- NCT07497360Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease
  Contact: Kıvanç Metin, PhD
- NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  Contact: Boehringer Ingelheim
- NCT04666038Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Dokuz Eylul Universitesi
Izmir, 35220
1 vizsgálat
- NCT05152147A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Dokuz Eylul Universitesi (Site 0740)
Izmir, 35340
1 vizsgálat
- NCT03867084Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
Dokuz Eylul Universitesi (Site 0959)
Izmir, 35340
1 vizsgálat
- NCT03711032Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Dokuz Eylül Üniversitesi (Site 5002)
Balçova, İzmir
1 vizsgálat
- NCT05008224Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
Dokuz Eylul University Faculty of Medicine - Neurology Department
Izmir, 35340
1 vizsgálat
- NCT06463587Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
  Contact: Ihsan Sengun (principal investigator)
Dokuz Eylul University Faculty of Medicine (Site 0505)
Izmir, 35330
1 vizsgálat
- NCT04732221A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
Dokuz Eylül University Faculty of Nursing
Izmir, İzmir
1 vizsgálat
- NCT06653673The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses
Dokuz Eylul University Medical School (Site # 1206)
Izmir, 35330
1 vizsgálat
- NCT06788990FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
  Contact: Principal Investigator

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Bipoláris zavar25 munka · 1 vizsgálat
Spondylitis ankylopoetica (Bechterew-kór)11 munka · 1 vizsgálat
Neuroblasztóma10 munka · 0 vizsgálat
Hepatitis B (krónikus)9 munka · 0 vizsgálat
Hypothyroidism8 munka · 0 vizsgálat
Coeliac disease5 munka · 0 vizsgálat
Graves' disease and hyperthyroidism5 munka · 0 vizsgálat
Lewy-testes demencia4 munka · 0 vizsgálat

Intézményadatok: ROR 00dbd8b73 (CC0-1.0)Frissítve: 2026. nov. 12.

Hibát jelzek